Published: Feb 3, 2026
Written by Klarity Editorial Team
Published: Feb 3, 2026

For the millions of Americans living with bipolar disorder, consistent access to medication is essential for stability and wellbeing. Telehealth has emerged as a convenient option for mental healthcare, but many patients and providers remain uncertain about the legal landscape for prescribing bipolar medications virtually. Can mood stabilizers like Lithium, Lamictal, and Seroquel be legally prescribed through video visits? Do you need an in-person exam first? Does it vary by state?
This comprehensive guide answers these questions with current regulatory information as of early 2026. We’ll clarify federal and state telehealth laws specifically for non-controlled bipolar medications, explain provider requirements, and help you understand what to expect from legitimate telehealth services like Klarity Health when seeking treatment.
The most important fact to understand is that the primary medications used to treat bipolar disorder—Lithium, Lamotrigine (Lamictal), and Quetiapine (Seroquel)—are not controlled substances under the Drug Enforcement Administration (DEA) classification system. This significantly simplifies their telehealth prescribing status.
Key Legal Point: Unlike ADHD stimulants or benzodiazepines (which are controlled substances with special restrictions), common bipolar medications can be legally prescribed via telehealth under federal law without requiring an in-person examination first.
The Ryan Haight Online Pharmacy Consumer Protection Act, which requires in-person examinations before prescribing controlled substances, does not apply to non-controlled medications like Lithium, Lamictal, or Seroquel. This means from a federal standpoint:
While the DEA has implemented temporary extensions for telehealth prescribing of controlled substances through December 31, 2026, these extensions are not necessary for the typical medications used in bipolar treatment, which have always been permitted for telehealth prescribing under federal law.
While federal law establishes a baseline, individual states regulate the practice of medicine and can impose additional requirements. The good news is that all 50 states permit telehealth prescribing of non-controlled medications like those used for bipolar disorder, though some have specific requirements worth understanding.
California: Yes. California explicitly allows the ‘appropriate prior examination’ to be done via telehealth for prescribing non-controlled medications. AB 1503 is proposing to further clarify telehealth standards, potentially allowing asynchronous screening in some cases.
Texas: Yes. Mental health teleprescribing is explicitly permitted for non-controlled medications. No in-person exam is required for mood stabilizers, though Texas does restrict telehealth prescribing of certain controlled substances.
New York: Yes. Non-controlled medications have no in-person requirements. A 2025 law instituted Ryan Haight-like rules for controlled substances but specifically exempted non-controlled medications like those used for bipolar treatment.
Florida: Yes. No in-person exam requirement exists for non-controlled medications under Florida law. While Florida does restrict telehealth prescribing of Schedule II controlled substances (with exceptions for psychiatric treatment), this doesn’t affect bipolar medications like Lithium or Lamictal.
New Hampshire: Yes, with periodic check-ins. A 2025 law (SB 252) requires that patients receiving ongoing prescriptions have an evaluation at least once per 12-month period, though this can be conducted via telehealth rather than in-person.
Pennsylvania, Illinois, Georgia, Delaware, and Alabama: Yes. These states permit telehealth prescribing of non-controlled medications with no specific in-person exam requirements beyond the standard of care.
The professional who provides your telehealth bipolar treatment matters under state law. While all states allow physicians (MDs and DOs) to prescribe non-controlled medications via telehealth, the rules for nurse practitioners (NPs) and physician assistants (PAs) vary by state.
Full Practice Authority States: In states like New York, Delaware, New Hampshire, and approximately 30 others, NPs can independently evaluate and prescribe non-controlled bipolar medications via telehealth without physician supervision (often after completing a transition period or gaining experience).
Collaborative Practice States: In Texas, Florida, Pennsylvania, Georgia, Alabama, and about 15 other states, NPs require some form of physician collaboration to prescribe. However, they can still provide telehealth treatment for bipolar disorder under this collaborative arrangement.
For instance, in Texas, NPs must operate under a Prescriptive Authority Agreement with a physician, while in Florida, they must practice under established protocols. In both cases, the NP can conduct the telehealth session and prescribe mood stabilizers while adhering to their state’s supervision requirements.
Important Note: While these state supervision rules impact how NPs practice, they do not prevent qualified NPs from providing telehealth treatment or prescribing non-controlled bipolar medications. Platforms like Klarity Health ensure their providers practice within the scope allowed by each state.
PDMPs are state databases that track controlled substance prescriptions. For non-controlled bipolar medications:
While legally permitted, telehealth prescribing of mood stabilizers comes with clinical responsibilities:
Lithium: Requires periodic blood level monitoring, kidney and thyroid function testsLamotrigine: Needs careful titration and monitoring for rash, particularly during initiationQuetiapine: Should include occasional metabolic monitoring (weight, blood sugar)
Reputable telehealth providers like Klarity Health coordinate these necessary tests by sending you to local labs and incorporating results into your treatment plan—all while maintaining the convenience of telehealth appointments.
Not every patient with bipolar disorder is an ideal candidate for telehealth treatment. While legal in most situations, clinical considerations determine appropriateness:
At Klarity Health, providers conduct thorough evaluations to determine if telehealth is appropriate for your specific situation, referring to in-person care when necessary for safety or optimal treatment.
When prescribed bipolar medication through a legitimate telehealth provider, you can expect a structured process:
Initial Evaluation: A comprehensive video assessment following DSM-5 criteria for bipolar disorder, including detailed history, symptom patterns, and ruling out other conditions
Documentation: The provider documents your telehealth consent, mental status examination findings, diagnosis, treatment rationale, and follow-up plan
Electronic Prescription: If medication is appropriate, the provider sends a secure e-prescription directly to your local pharmacy
Typical Supply: Providers often prescribe a 30-day initial supply, potentially increasing to 90-day supplies with refills once stabilized
Follow-up Schedule: Expect regular video follow-ups to monitor effectiveness, side effects, and adjust treatment as needed
Lab Coordination: For medications like Lithium, providers will order necessary bloodwork before or shortly after starting medication, with results reviewed during follow-up
Find the right provider for your needs — select your state to find expert care near you.